MLN4924 Compared With MLN4924 Plus Chemotherapy for Large B-cell Lymphoma

NCT01415765 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

NIH

Sponsor class

Conditions

Lymphoma, Diffuse Large-Cell B-cell
Diffuse, Large B-cell Lymphoma
Lymphoma, Diffuse Large-Cell
Large-Cell Lymphoma, Diffuse

Interventions

DRUG: MLN4924
DRUG: Etoposide
DRUG: Prednisone
DRUG: Vincristine
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Rituximab
DRUG: Filgrastim

Sponsor

National Cancer Institute (NCI)